サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566967

ボーンワックス市場：製品別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Bone Wax Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ボーンワックス市場：製品別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ボーンワックス市場は、2023年に5,310万米ドルと評価され、2024～2033年にかけてCAGR 3.2％で成長し、2033年には7,300万米ドルに達すると予測されています。

ボーンワックスは、蜜蝋、パラフィン、ワックス軟化剤であるパルミチン酸イソプロピルの混合物であり、骨表面からの出血を抑制する外科処置に使用されます。その柔軟な性質により、容易に成形して骨に直接塗布することができ、血管を機械的に遮断することで出血箇所を効果的に封鎖することができます。ボーンワックスは、整形外科、神経外科、心臓胸部外科の手術で、特に胸骨や出血しやすい骨を扱う場合によく使用されます。

世界のボーンワックス市場の成長は、整形外科、神経外科、心臓血管外科の手術件数の増加が牽引しています。米国国立衛生研究所（National Institutes of Health）が2020年に発表した調査によると、毎年約3億1,000万件の大手術が行われており、米国では約4,000万～5,000万件、欧州では約2,000万件となっています。さらに、高齢者人口の急増も市場成長に大きく寄与しています。これは、高齢者が骨粗鬆症やその他の骨関連疾患にかかりやすいことに起因しています。高齢者の骨はミネラルが流出し始め、もろく壊れやすくなるため、ボーンワックスが必要となります。世界保健機関（WHO）によると、60歳以上の高齢者の数は2019年に10億人でした。この数は2030年には14億人、2050年には21億人に増加すると推定されています。さらに、大きな動向として生分解性ボーンワックスの市場開拓と採用があり、これが市場の成長を大きく後押ししています。非再吸収性である従来のボーンワックスは、骨治癒障害や感染症などの合併症と関連しています。これに対し、メーカーは出血を効果的に抑制しながらも、こうしたリスクを軽減する生体吸収性の選択肢を導入しています。しかし、従来のボーンワックスに関連する懸念が市場の成長を妨げています。例えば、従来のボーンワックスは非再吸収性であり、骨治癒障害、異物反応、感染リスクの増加などの合併症を引き起こす可能性があります。さらに、フィブリンシーラント、ゼラチンスポンジ、酸化セルロースなどの代替止血剤が入手しやすく、好まれていることも、ボーンワックス市場の成長を抑制しています。逆に、手術手技の革新や、より効率的で生体適合性の高いボーンワックス製剤の開拓は、予測期間中の市場成長に有利な機会を提供しています。さらに、手術部位感染に対する意識の高まりに伴い、抗菌特性を組み込んだボーンワックス製品に対する動向が高まっています。このような高度な製剤は、特に脊椎や頭蓋を含むようなリスクの高い手術において、術後感染のリスクを低減することを目的としています。このような発展は、今後数年の市場成長に新たな道を開くと期待されています。

世界のボーンワックス市場は、製品、用途、エンドユーザー、地域に区分されます。製品別では、吸収性ボーンワックスと非吸収性ボーンワックスに分けられます。用途別では、整形外科、胸部外科、神経外科、その他に分類されます。エンドユーザー別では、専門クリニック、病院、外来手術センターに分類されます。地域別では、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

製品別では、非吸収性ボーンワックスセグメントが2023年にシェアで市場を独占しました。

用途別では、整形外科セグメントが2023年の主要株主でした。

エンドユーザー別では、病院セグメントが2023年の主要セグメントとして浮上しました。

地域別では、北米が2023年の市場シェアを独占したが、アジア太平洋が予測期間中に最も高いCAGRを記録する見込みです。

本レポートのカスタマイズが可能です（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 ボーンワックス市場：製品別

  • 市場概要
  • 吸収性ボーンワックス
  • 非吸収性ボーンワックス

第5章 ボーンワックス市場：用途別

  • 市場概要
  • 整形外科
  • 胸部外科
  • 脳神経外科
  • その他

第6章 ボーンワックス市場：エンドユーザー別

  • 市場概要
  • 専門クリニック
  • 病院
  • 外来手術センター

第7章 ボーンワックス市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国のボーンワックス市場
    • カナダのボーンワックス市場
    • メキシコのボーンワックス市場
  • 欧州
    • 主要市場動向と機会
    • ドイツのボーンワックス市場
    • フランスのボーンワックス市場
    • 英国のボーンワックス市場
    • イタリアのボーンワックス市場
    • スペインのボーンワックス市場
    • その他の欧州のボーンワックス市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本のボーンワックス市場
    • 中国のボーンワックス市場
    • オーストラリアのボーンワックス市場
    • インドのボーンワックス市場
    • 韓国のボーンワックス市場
    • その他のアジア太平洋のボーンワックス市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのボーンワックス市場
    • サウジアラビアのボーンワックス市場
    • 南アフリカのボーンワックス市場
    • その他のラテンアメリカ・中東・アフリカのボーンワックス市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Zimmer Biomet Holdings, Inc.
  • Medline Industries, Inc.
  • Medtronic Plc
  • B Braun Melsungen AG
  • Baxter International, Inc
  • Johnson And Johnson
  • Dolphin Sutures
  • SMI AG
  • Orion Sutures India Pvt. Ltd
  • Universal Suture
目次
Product Code: A324382

The bone wax market was valued at $53.1 million in 2023, and is projected to reach $73.0 million by 2033, growing at a CAGR of 3.2% from 2024 to 2033.

Bone wax is a mixture of beeswax, paraffin, and isopropyl palmitate, a wax-softening agent, used in surgical procedures to control bleeding from bone surfaces. Its pliable nature allows it to be easily molded and applied directly to the bone, effectively sealing bleeding points by mechanically blocking blood vessels. Bone wax is commonly used in orthopedic, neurosurgical, and cardiothoracic surgeries, particularly when working with the sternum or other bones prone to bleeding.

The growth of the global bone wax market is driven by rise in number of orthopedic, neurosurgical, and cardiovascular surgeries. According to a study published in 2020 by the National Institutes of Health-world's foremost medical research centers-approximately 310 million major surgeries are performed each year; around 40 to 50 million in the U.S. and 20 million in Europe. Furthermore, surge in geriatric population notably contributes toward the market growth. This is attributed to the fact that aged individuals are highly susceptible to conditions such as osteoporosis and other bone-related diseases, as minerals in bones of aged individuals start to leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone wax. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, a significant trend is the development and adoption of biodegradable bone wax, which significantly boosts the market growth. Traditional bone wax, which is non-resorbable, has been associated with complications like impaired bone healing and infection. In response, manufacturers are introducing bioresorbable options that reduce these risks while still effectively controlling bleeding. However, concerns associated with traditional bone wax hamper the market growth. For instance, traditional bone wax is non-resorbable and can lead to complications such as impaired bone healing, foreign body reactions, and an increased risk of infection. Moreover, availability and preference for alternative hemostatic agents, such as fibrin sealants, gelatin sponges, and oxidized cellulose, which may offer better resorption and fewer complications, are restraining the growth of the bone wax market. On the contrary, innovations in surgical techniques and the development of more efficient and biocompatible bone wax formulations are offering lucrative opportunities for the market growth during the forecast period. Furthermore, with heightened awareness of surgical site infections, there is a growing trend toward bone wax products that incorporate antimicrobial properties. These advanced formulations aim to reduce the risk of post-operative infections, particularly in high-risk surgeries such as those involving the spine or cranium. Such developments are expected to open new avenues for the market growth in the coming years.

The global bone wax market is segmented into product, application, end user, and region. By product, the market is divided into absorbable bone wax and non-absorbable bone wax. On the basis of application, it is classified into orthopedic surgery, thoracic surgery, neurosurgery, and others. Depending on end user, it is categorized into specialty clinics, hospitals, and ambulatory surgery centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the non-absorbable bone wax segment dominated the market, in terms of share, in 2023.

On the basis of application, the orthopedic segment was the major shareholder in 2023.

Depending on end user, hospital emerged as the leading segment in 2023.

Region wise, North America dominated the market share in 2023; however, Asia-Pacific is expected to register the highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bone wax market include Zimmer Biomet Holdings, Inc., Medline Industries, Inc., Medtronic Plc, B Braun Melsungen AG, Baxter International, Inc, Johnson & Johnson, Dolphin Sutures, SMI AG, Orion Sutures India Pvt. Ltd., and Universal Suture These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Absorbable Bone Wax
  • Non-Absorbable Bone Wax

By Application

  • Orthopedic Surgery
  • Thoracic Surgery
  • Neurosurgery
  • Others

By End User

  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgery Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Zimmer Biomet Holdings, Inc.
    • Medline Industries, Inc.
    • Medtronic plc
    • B Braun Melsungen AG
    • Baxter International, Inc
    • Johnson & Johnson
    • Dolphin Sutures
    • SMI AG
    • Orion Sutures India Pvt. Ltd
    • Universal Suture

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BONE WAX MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Absorbable Bone Wax
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Non-Absorbable Bone Wax
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: BONE WAX MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Orthopedic Surgery
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Thoracic Surgery
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Neurosurgery
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: BONE WAX MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Specialty Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Hospitals
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Ambulatory Surgery Centers
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BONE WAX MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Bone Wax Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Bone Wax Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Bone Wax Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Bone Wax Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Bone Wax Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Bone Wax Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Bone Wax Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Bone Wax Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Bone Wax Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Bone Wax Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Bone Wax Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Bone Wax Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Bone Wax Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Bone Wax Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Bone Wax Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Bone Wax Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Bone Wax Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Bone Wax Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Bone Wax Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Zimmer Biomet Holdings, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Medline Industries, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Medtronic Plc
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. B Braun Melsungen AG
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Baxter International, Inc
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Johnson And Johnson
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Dolphin Sutures
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. SMI AG
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Orion Sutures India Pvt. Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Universal Suture
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments